Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Pharm Dev Technol., Feb (2012)
Cutting-edge technologies in colon-targeted drug delivery systems.
Expert Opin Drug Deliv., Oct;8(10):1247-58 (2011)
Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
J Pharm Sci., May;100(5):1760-72 (2011)
Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
Drug Deliv., May;18(4):281-93 (2011)
Angiogenic targets for potential disorders.
Fundam Clin Pharmacol., Feb;25(1):29-47 (2011)
Therapeutic opportunities of small interfering RNA.
Fundam Clin Pharmacol., Aug;23(4):367-86 (2009)
Getting into the brain: approaches to enhance brain drug delivery.
CNS Drugs., 23(1):35-58 (2009)
Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
Pharm Dev Technol., 14(1):62-9 (2009)
Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome.
Int. J. Radiat. Oncol. Biol. Phys., Dec;42(5):1077-84 (1998)